CML development is generally caused by expression of BCR‐ABL1 fusion protein, which leads to genomic instability, and the malignant progression from the CP to the BC phase occurs in a BCR‐ABL1‐dependent or ‐independent manner.35, 36. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.